Kura Oncology, Inc. (NASDAQ:KURA), a clinical-stage biopharmaceutical company focused on developing precision medicines for cancer treatment, is approaching a critical juncture in its development ...

We recently published a list of Top 10 Trending AI News On Wall Street’s Radar. In this article, we are going to take a look ...

Abu Dhabi-based healthcare company purchases 80% stake in the Dubai-based Advanced Care Oncology Center for $25mn ...

Compugen's innovative approach targets under-explored immune pathways like PVRIG and IL-18 binding protein. Read why I'm ...

Trust in AI is a crucial determinant of its integration into clinical practice. The study measured clinician trust levels and ...

Cardiff Oncology's Onvansertib shows promise in treating RAS-mutated cancers, especially mCRC. See why I rate CRDF stock as a ...

In mid-2024, the commercial president of Pfizer’s oncology unit Suneet Varma announced his retirement after 15 years with the ...

The North Chicago drugmaker says it could pay Xilio Therapeutics more than $2.1 billion in a collaboration and ...

Burjeel Holdings has announced its plan to establish the leading radiation oncology network in the GCC, following its ...

Oncology Nursing Society and Adtalem have partnered to offer Chamberlain nursing students a free course providing an introduction to oncology nursing ...

Andrea Roman, PharmD, BCOP, US Oncology Network and McKesson, discussed the integration of clinical pharmacists into ...

Susan Escudier, MD, FACP, explains some of the ways Texas Oncology mitigates financial toxicity and improve clinical trial access for underserved patients.